Galectin-3 overrides PTRF/cavin-1 reduction of PC3 prostate cancer cell migration

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Meng, Fanrui ^a   Joshi, Bharat ^a   Nabi, Ivan Robert ^a  

^a Life Sciences Institute   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; CYTOPLASM PROTEIN; FOCAL ADHESION KINASE; GALECTIN 3; POLYMERASE I AND TRANSCRIPT RELEASE FACTOR; UNCLASSIFIED DRUG; HYBRID PROTEIN; PTRF PROTEIN, HUMAN; RNA BINDING PROTEIN;

ARTICLE; CANCER CELL; CAVEOLA; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; ENZYME STABILITY; FOCAL ADHESION; HUMAN; HUMAN CELL; MALE; PROSTATE CANCER CELL LINE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; BIOLOGICAL MODEL; CELL MOTION; DRUG EFFECTS; GENE EXPRESSION; GENE SILENCING; GENETICS; METABOLISM; PATHOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL MOVEMENT; ENZYME STABILITY; FOCAL ADHESION PROTEIN-TYROSINE KINASES; FOCAL ADHESIONS; GALECTIN 3; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HUMANS; MALE; MODELS, BIOLOGICAL; PROSTATIC NEOPLASMS; RECOMBINANT FUSION PROTEINS; RNA-BINDING PROTEINS;

EID: 84929083346     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126056     Document Type: Article

References (54)

1. Parton RG, Del Pozo MA. Caveolae as plasma membrane sensors, protectors and organizers. Nature reviews Molecular cell biology. 2013; 14(2):98-112. Epub 2013/01/24. doi: 10.1038/nrm3512 PMID: 23340574
2. Navarro A, Anand-Apte B, Parat MO. A role for caveolae in cell migration. FASEB J. 2004; 18(15):1801-11. Epub 2004/12/04. PMID: 15576483
3. Williams TM, Lisanti MP. Caveolin-1 in oncogenic transformation, cancer, and metastasis. American journal of physiology Cell physiology. 2005; 288(3):C494-506. Epub 2005/02/05. PMID: 15692148
4. Goetz JG, Joshi B, Lajoie P, Strugnell SS, Scudamore T, Kojic LD, et al. Concerted regulation of focal adhesion dynamics by galectin-3 and tyrosine-phosphorylated caveolin-1. J Cell Biol. 2008; 180(6):1261-75. Epub 2008/03/19. doi: 10.1083/jcb.200709019 PMID: 18347068
5. Yang G, Truong LD, Timme TL, Ren C, Wheeler TM, Park SH, et al. Elevated expression of caveolin is associated with prostate and breast cancer. Clinical cancer research: an official journal of the American Association for Cancer Research. 1998; 4(8):1873-80. Epub 1998/08/26.
6. Yang G, Truong LD, Wheeler TM, Thompson TC. Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker. Cancer Res. 1999; 59(22):5719-23. Epub 1999/12/03. PMID: 10582690
7. Gould ML, Williams G, Nicholson HD. Changes in caveolae, caveolin, and polymerase 1 and transcript release factor (PTRF) expression in prostate cancer progression. Prostate. 2010; 70(15):1609-21. Epub 2010/06/22. doi: 10.1002/pros.21195 PMID: 20564315
8. Li L, Yang G, Ebara S, Satoh T, Nasu Y, Timme TL, et al. Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells. Cancer Res. 2001; 61(11):4386-92. Epub 2001/06/05. PMID: 11389065
9. Hill MM, Bastiani M, Luetterforst R, Kirkham M, Kirkham A, Nixon SJ, et al. PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell. 2008; 132(1):113-24. Epub 2008/01/15. doi: 10.1016/j.cell.2007.11.042 PMID: 18191225
10. Hayer A, Stoeber M, Bissig C, Helenius A. Biogenesis of caveolae: stepwise assembly of large caveolin and cavin complexes. Traffic. 2010; 11(3):361-82. Epub 2010/01/15. doi: 10.1111/j.1600-0854.2009.01023.x PMID: 20070607
11. Joshi B, Strugnell SS, Goetz JG, Kojic LD, Cox ME, Griffith OL, et al. Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion. Cancer Res. 2008; 68(20):8210-20. Epub 2008/10/17. doi: 10.1158/0008-5472.CAN-08-0343 PMID: 18922892
12. Aung CS, Hill MM, Bastiani M, Parton RG, Parat MO. PTRF-cavin-1 expression decreases the migration of PC3 prostate cancer cells: role of matrix metalloprotease 9. Eur J Cell Biol. 2011; 90(2-3):136-42. Epub 2010/08/25.
13. Inder KL, Zheng YZ, Davis MJ, Moon H, Loo D, Nguyen H, et al. Expression of PTRF in PC-3 Cells modulates cholesterol dynamics and the actin cytoskeleton impacting secretion pathways. Molecular &cellular proteomics: MCP. 2012; 11(2):M111 012245. Epub 2011/10/28.
14. Moon H, Lee CS, Inder KL, Sharma S, Choi E, Black DM, et al. PTRF/cavin-1 neutralizes non-caveolar caveolin-1 microdomains in prostate cancer. Oncogene. 2014; 33(27):3561-70. Epub 2013/08/13. doi: 10.1038/onc.2013.315 PMID: 23934189
15. Lauffenburger DA, Horwitz AF. Cell migration: a physically integrated molecular process. Cell. 1996; 84(3):359-69. Epub 1996/02/09. PMID: 8608589
16. Ridley AJ, Schwartz MA, Burridge K, Firtel RA, Ginsberg MH, Borisy G, et al. Cell migration: integrating signals from front to back. Science. 2003; 302(5651):1704-9. Epub 2003/12/06. PMID: 14657486
17. Gupton SL, Waterman-Storer CM. Spatiotemporal feedback between actomyosin and focal-adhesion systems optimizes rapid cell migration. Cell. 2006; 125(7):1361-74. Epub 2006/07/04. PMID: 16814721
18. Burridge K, Fath K. Focal contacts: transmembrane links between the extracellular matrix and the cytoskeleton. BioEssays: news and reviews in molecular, cellular and developmental biology. 1989; 10-(4):104-8. Epub 1989/04/01.
19. Chen CS, Alonso JL, Ostuni E, Whitesides GM, Ingber DE. Cell shape provides global control of focal adhesion assembly. Biochemical and biophysical research communications. 2003; 307(2):355-61. Epub 2003/07/16. PMID: 12859964
20. Giannone G, Ronde P, Gaire M, Beaudouin J, Haiech J, Ellenberg J, et al. Calcium rises locally trigger focal adhesion disassembly and enhance residency of focal adhesion kinase at focal adhesions. J Biol Chem. 2004; 279(27):28715-23. Epub 2004/04/23. PMID: 15102844
21. Hamadi A, Bouali M, Dontenwill M, Stoeckel H, Takeda K, Ronde P. Regulation of focal adhesion dynamics and disassembly by phosphorylation of FAK at tyrosine 397. Journal of cell science. 2005; 118 (Pt 19):4415-25. Epub 2005/09/15. PMID: 16159962
22. Gaus K, Le Lay S, Balasubramanian N, Schwartz MA. Integrin-mediated adhesion regulates membrane order. J Cell Biol. 2006; 174(5):725-34. Epub 2006/09/01. PMID: 16943184
23. Glenney JR Jr. Tyrosine phosphorylation of a 22-kDa protein is correlated with transformation by Rous sarcoma virus. J Biol Chem. 1989; 264(34):20163-6. Epub 1989/12/05. PMID: 2479645
24. Glenney JR Jr., Zokas L. Novel tyrosine kinase substrates from Rous sarcoma virus-transformed cells are present in themembrane skeleton. J Cell Biol. 1989; 108(6):2401-8. Epub 1989/06/01. PMID: 2472406
25. Li S, Seitz R, Lisanti MP. Phosphorylation of caveolin by src tyrosine kinases. The alpha-isoform of caveolin is selectively phosphorylated by v-Src in vivo. J Biol Chem. 1996; 271(7):3863-8. Epub 1996/02/16. PMID: 8632005
26. Grande-Garcia A, Echarri A, de Rooij J, Alderson NB, Waterman-Storer CM, Valdivielso JM, et al. Caveolin-1 regulates cell polarization and directional migration through Src kinase and Rho GTPases. J Cell Biol. 2007; 177(4):683-94. Epub 2007/05/23. PMID: 17517963
27. Granovsky M, Fata J, Pawling J, Muller WJ, Khokha R, Dennis JW. Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nature medicine. 2000; 6(3):306-12. Epub 2000/03/04. PMID: 10700233
28. Lagana A, Goetz JG, Cheung P, Raz A, Dennis JW, Nabi IR. Galectin binding to Mgat5-modified Nglycans regulates fibronectin matrix remodeling in tumor cells. Molecular and cellular biology. 2006; 26-(8):3181-93. Epub 2006/04/04. PMID: 16581792
29. Dumic J, Dabelic S, Flogel M. Galectin-3: an open-ended story. Biochimica et biophysica acta. 2006; 1760(4):616-35. Epub 2006/02/16. PMID: 16478649
30. Saravanan C, Liu FT, Gipson IK, Panjwani N. Galectin-3 promotes lamellipodia formation in epithelial cells by interacting with complex N-glycans on alpha3beta1 integrin. Journal of cell science. 2009; 122 (Pt 20):3684-93. Epub 2009/09/17. doi: 10.1242/jcs.045674 PMID: 19755493
31. Shankar J, Wiseman SM, Meng F, Kasaian K, Strugnell S, Mofid A, et al. Coordinated expression of galectin-3 and caveolin-1 in thyroid cancer. The Journal of pathology. 2012; 228(1):56-66. Epub 2012/04/20. doi: 10.1002/path.4041 PMID: 22513979
32. Dennis JW, Nabi IR, Demetriou M. Metabolism, cell surface organization, and disease. Cell. 2009; 139-(7):1229-41. Epub 2010/01/13. doi: 10.1016/j.cell.2009.12.008 PMID: 20064370 33.
33. Dennis JW, Brewer CF. Density-dependent lectin-glycan interactions as a paradigm for conditional regulation by posttranslational modifications. Molecular & cellular proteomics: MCP. 2013; 12(4):913-20. Epub 2013/02/05.
34. Hansen CG, Nichols BJ. Exploring the caves: cavins, caveolins and caveolae. Trends Cell Biol. 2010; 20(4):177-86. Epub 2010/02/16. doi: 10.1016/j.tcb.2010.01.005 PMID: 20153650
35. Liu L, Pilch PF. A critical role of cavin (polymerase I and transcript release factor) in caveolae formation and organization. J Biol Chem. 2008; 283(7):4314-22. Epub 2007/12/07. PMID: 18056712
36. Lajoie P, Goetz JG, Dennis JW, Nabi IR. Lattices, rafts, and scaffolds: domain regulation of receptor signaling at the plasma membrane. J Cell Biol. 2009; 185(3):381-5. Epub 2009/04/29. doi: 10.1083/jcb. 200811059 PMID: 19398762
37. Lajoie P, Kojic LD, Nim S, Li L, Dennis JW, Nabi IR. Caveolin-1 regulation of dynamin-dependent, raftmediated endocytosis of cholera toxin-B sub-unit occurs independently of caveolae. Journal of cellular and molecular medicine. 2009; 13(9B):3218-25. Epub 2009/05/15. doi: 10.1111/j.1582-4934.2009.00732.x PMID: 19438805
38. Zheng YZ, Boscher C, Inder KL, Fairbank M, Loo D, Hill MM, et al. Differential impact of caveolae and caveolin-1 scaffolds on the membrane raft proteome. Molecular & cellular proteomics: MCP. 2011; 10(10):M110 007146. Epub 2011/07/15.
39. Hill MM, Daud NH, Aung CS, Loo D, Martin S, Murphy S, et al. Co-regulation of cell polarization and migration by caveolar proteins PTRF/Cavin-1 and caveolin-1. PLoS One. 2012; 7(8):e43041. Epub 2012/08/23. doi: 10.1371/journal.pone.0043041 PMID: 22912783
40. Nassar ZD, Moon H, Duong T, Neo L, Hill MM, Francois M, et al. PTRF/Cavin-1 decreases prostate cancer angiogenesis and lymphangiogenesis. Oncotarget. 2013; 4(10):1844-55. Epub 2013/10/15. PMID: 24123650
41. Boscher C, Nabi IR. Galectin-3- and phospho-caveolin-1-dependent outside-in integrin signaling mediates the EGF motogenic response in mammary cancer cells. Mol Biol Cell. 2013; 24(13):2134-45. Epub 2013/05/10. doi: 10.1091/mbc.E13-02-0095 PMID: 23657817
42. Nomura R, Fujimoto T. Tyrosine-phosphorylated caveolin-1: immunolocalization and molecular characterization. Mol Biol Cell. 1999; 10(4):975-86. Epub 1999/04/10. PMID: 10198051
43. Parton RG, Hanzal-Bayer M, Hancock JF. Biogenesis of caveolae: a structural model for caveolininduced domain formation. Journal of cell science. 2006; 119(Pt 5):787-96. Epub 2006/02/24. PMID: 16495479
44. Demetriou M, Nabi IR, Coppolino M, Dedhar S, Dennis JW. Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V. J Cell Biol. 1995; 130(2):383-92. Epub 1995/07/01. PMID: 7615638
45. Wei Y, Yang X, Liu Q, Wilkins JA, Chapman HA. A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling. J Cell Biol. 1999; 144(6):1285-94. Epub 1999/03/24. PMID: 10087270
46. del Pozo MA, Balasubramanian N, Alderson NB, Kiosses WB, Grande-Garcia A, Anderson RG, et al. Phospho-caveolin-1 mediates integrin-regulated membrane domain internalization. Nat Cell Biol. 2005; 7(9):901-8. Epub 2005/08/23. PMID: 16113676
47. Radel C, Rizzo V. Integrin mechanotransduction stimulates caveolin-1 phosphorylation and recruitment of Csk to mediate actin reorganization. Am J Physiol Heart Circ Physiol. 2005; 288(2):H936-45. Epub 2004/10/09. PMID: 15471980
48. Fukumori T, Oka N, Takenaka Y, Nangia-Makker P, Elsamman E, Kasai T, et al. Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancer. Cancer Res. 2006; 66(6):3114-9. Epub 2006/03/17. PMID: 16540661
49. Wang Y, Nangia-Makker P, Balan V, Hogan V, Raz A. Calpain activation through galectin-3 inhibition sensitizes prostate cancer cells to cisplatin treatment. Cell death & disease. 2010; 1:e101. Epub 2010/01/01.
50. Wang Y, Balan V, Gao X, Reddy PG, Kho D, Tait L, et al. The significance of galectin-3 as a new basal cell marker in prostate cancer. Cell death & disease. 2013; 4:e753. Epub 2013/08/03.
51. Glinskii OV, Sud S, Mossine VV, Mawhinney TP, Anthony DC, Glinsky GV, et al. Inhibition of prostate cancer bone metastasis by synthetic TF antigen mimic/galectin-3 inhibitor lactulose-L-leucine. Neoplasia. 2012; 14(1):65-73. Epub 2012/02/23. PMID: 22355275
52. Guha P, Kaptan E, Bandyopadhyaya G, Kaczanowska S, Davila E, Thompson K, et al. Cod glycopeptide with picomolar affinity to galectin-3 suppresses T-cell apoptosis and prostate cancermetastasis. Proceedings of the National Academy of Sciences of the United States of America. 2013; 110(13):5052-7. Epub 2013/03/13. doi: 10.1073/pnas.1202653110 PMID: 23479624
53. Henderson NC, Mackinnon AC, Farnworth SL, Poirier F, Russo FP, Iredale JP, et al. Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proceedings of the National Academy of Sciences of the United States of America. 2006; 103(13):5060-5. Epub 2006/03/22. PMID: 16549783
54. Wallner M, Gruber P, Radauer C, Maderegger B, Susani M, Hoffmann-Sommergruber K, et al. Lab scale and medium scale production of recombinant allergens in Escherichia coli. Methods. 2004; 32(3):219-26. Epub 2004/02/14. PMID: 14962755